Celldex Therapeutics, Inc. · NASDAQ:CLDX

Point72 Asset Management, L.P.'s stake in Celldex Therapeutics, Inc. fell to 2.60% (Schedule 13G/A)

Event Dec 31, 2025 · Filed Mar 10, 2026

Point72 Asset Management, L.P.'s stake in Celldex Therapeutics, Inc. fell to 2.60%, 1,758,357 shares, as a passive investor on Dec 31, 2025. Filed Mar 10, 2026 (Schedule 13G/A).

Stake
2.60%
Shares
1,758,357
Intent
Passive
What changed
Fell below 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Point72 Asset Management, L.P.2.60%1,758,357
Point72 Capital Advisors, Inc.2.60%1,758,357
Steven A. Cohen2.60%1,758,357

Source

View original at SEC

Related